Several members of an FDA advisory committee warned on Monday that new data from studies on long-term use of opioids might ...

Function Health is buying Ezra in a bid to create a haven for people who want copious amounts of data on their bodies. The ...

Deerfield Management is back with its third healthcare venture fund, this time securing more than $600 million to create new ...

Topas Therapeutics reveals first data from celiac disease therapy study, showing promise in immune system retraining with ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

J&J's gene therapy bota-vec failed Phase 3 trial for X-linked retinitis pigmentosa vision loss. Follows trend of big pharma ...

Not many would argue that Biotech is one of the riskiest industries on the globe. With costs hovering in the hundreds of millions of dollars, competitors ...